Market Overview:
The global drug discovery technologies market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for novel drugs and therapies, rising prevalence of chronic diseases, and growing investments in R&D by biopharmaceutical companies. Based on type, the global drug discovery technologies market is segmented into biochips, high throughput screening (HTS), pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology and others. Biochips are expected to be the fastest-growing segment during the forecast period owing to their ability to reduce time-to-market for new drugs and therapies. Based on application, the global drug discovery technologies market is segmented into biopharmaceutical companies; pharmaceutical companies; research institutes; biotech companies; and others (government organizations & academic institutions). Biopharmaceutical companies are expected to account for the largest share of the market in 2018 owing to their large R&D budgets and need for novel drugs & therapies.
Product Definition:
Drug discovery technology is the use of various technologies to help in the process of drug discovery. This can include anything from using computer programs to predict how a new drug will interact with proteins in the body, to using cell cultures to test how effective a potential new drug is at inhibiting or killing cancer cells. Drug discovery technology is important because it can help speed up and improve the accuracy of the drug discovery process.
Biochips:
Biochips are artificial organs that are used in the detection and identification of biological molecules such as DNA, RNA, hormones, enzymes and toxins. Biochips enable laboratories to perform specific tests on blood or urine samples for the detection of diseases such as HIV AIDS or cancer.
High throughput screening:
High Throughput Screening (HTS) is a new drug discovery technology that helps in screening of large number of compounds at the same time with higher speed and efficiency. It reduces the time taken to identify active ingredients in drugs, hence increasing its utility for drug discovery technologies market.
The major driving factors responsible for growth of high throughput screening are reduction in cost associated with it's implementation and need for smaller testing sample size which further reduce cost involved during its usage.
Application Insights:
The biopharmaceutical companies segment dominated the global market in 2017. This is attributed to factors such as presence of a large number of biopharmaceutical companies and increase in R&D activities pertaining to new drug development. Furthermore, increasing government funding for research related to infectious diseases, cancer & oncology, and cardiovascular diseases is expected to boost the demand for ADDT technologies over the forecast period.
Pharmaceutical companies are also anticipated to exhibit lucrative growth owing to extensive research & development activities pertaining with new drug discovery and ongoing clinical trials coupled with an increasing number of approvals by regulatory authorities such as FDA (U.S.) and EMA (Europe).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biopharmaceutical and pharmaceutical companies, which are among the key users of these technologies. The region is expected to maintain its dominance throughout the forecast period owing to continuous technological advancements as well as increasing R&D expenditure by various companies. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments in developing economies for generating revenue through exports and domestic sales, especially in countries such as China, India, South Korea & Japan.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases such as cancer, cardiovascular disease, diabetes, and respiratory disorders are responsible for over 60% of all deaths worldwide. This presents a huge opportunity for drug discovery technologies market as they can help in the development of novel therapeutics to treat these conditions.
- Advances in genomics and proteomics: The field of genomics has made rapid strides in recent years with the advent of next-generation sequencing technologies. Similarly, proteomics has also seen significant advances with the development of mass spectrometry techniques and other analytical tools. These advances have helped researchers gain a better understanding about how proteins interact with each other and how they contribute to disease pathology. This knowledge can be used to develop better drugs that target specific proteins involved in causing disease processes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Discovery Technologies Market Research Report
By Type
Biochips, High throughput screening, Pharmacogenomics, Genomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, Others
By Application
Biopharmaceutical companies, Pharmaceutical companies, Research institutes, Biotech companies
By Companies
Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, Astrazeneca plc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Drug Discovery Technologies Market Report Segments:
The global Drug Discovery Technologies market is segmented on the basis of:
Types
Biochips, High throughput screening, Pharmacogenomics, Genomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical companies, Pharmaceutical companies, Research institutes, Biotech companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies, Inc
- Abbott Laboratories, Inc.
- GE Healthcare Ltd.
- Albany Molecular Research Inc.
- Affymetrix Inc.
- Arqule Inc.
- Luminex Corporation
- Bayer Healthcare AG
- Novartis AG
- Astrazeneca plc
Highlights of The Drug Discovery Technologies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biochips
- High throughput screening
- Pharmacogenomics
- Genomics
- Bioanalytical instruments
- Bioinformatics
- Nanotechnology
- Others
- By Application:
- Biopharmaceutical companies
- Pharmaceutical companies
- Research institutes
- Biotech companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Discovery Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug discovery technologies are a set of methods and tools used to identify new drugs. These technologies can be divided into two categories: chemical screening and biological screening. Chemical screening uses traditional drug discovery techniques, such as pharmacology, toxicology, and structure-activity relationships (SAR), to identify potential drug candidates. Biological screening uses techniques such as cell culture assays or animal models to screen for the effects of potential drugs on cells or animals.
Some of the major companies in the drug discovery technologies market are Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, Astrazeneca plc.
The drug discovery technologies market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Discovery Technologies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Discovery Technologies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Discovery Technologies Market - Supply Chain
4.5. Global Drug Discovery Technologies Market Forecast
4.5.1. Drug Discovery Technologies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Discovery Technologies Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Discovery Technologies Market Absolute $ Opportunity
5. Global Drug Discovery Technologies Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Discovery Technologies Market Size and Volume Forecast by Type
5.3.1. Biochips
5.3.2. High throughput screening
5.3.3. Pharmacogenomics
5.3.4. Genomics
5.3.5. Bioanalytical instruments
5.3.6. Bioinformatics
5.3.7. Nanotechnology
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Discovery Technologies Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Discovery Technologies Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical companies
6.3.2. Pharmaceutical companies
6.3.3. Research institutes
6.3.4. Biotech companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Discovery Technologies Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Discovery Technologies Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Discovery Technologies Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Discovery Technologies Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Discovery Technologies Demand Share Forecast, 2019-2029
9. North America Drug Discovery Technologies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Discovery Technologies Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Discovery Technologies Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical companies
9.4.2. Pharmaceutical companies
9.4.3. Research institutes
9.4.4. Biotech companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Discovery Technologies Market Size and Volume Forecast by Type
9.7.1. Biochips
9.7.2. High throughput screening
9.7.3. Pharmacogenomics
9.7.4. Genomics
9.7.5. Bioanalytical instruments
9.7.6. Bioinformatics
9.7.7. Nanotechnology
9.7.8. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Discovery Technologies Demand Share Forecast, 2019-2029
10. Latin America Drug Discovery Technologies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Discovery Technologies Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Discovery Technologies Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical companies
10.4.2. Pharmaceutical companies
10.4.3. Research institutes
10.4.4. Biotech companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Discovery Technologies Market Size and Volume Forecast by Type
10.7.1. Biochips
10.7.2. High throughput screening
10.7.3. Pharmacogenomics
10.7.4. Genomics
10.7.5. Bioanalytical instruments
10.7.6. Bioinformatics
10.7.7. Nanotechnology
10.7.8. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Discovery Technologies Demand Share Forecast, 2019-2029
11. Europe Drug Discovery Technologies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Discovery Technologies Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Discovery Technologies Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical companies
11.4.2. Pharmaceutical companies
11.4.3. Research institutes
11.4.4. Biotech companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug Discovery Technologies Market Size and Volume Forecast by Type
11.7.1. Biochips
11.7.2. High throughput screening
11.7.3. Pharmacogenomics
11.7.4. Genomics
11.7.5. Bioanalytical instruments
11.7.6. Bioinformatics
11.7.7. Nanotechnology
11.7.8. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Discovery Technologies Demand Share, 2019-2029
12. Asia Pacific Drug Discovery Technologies Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Discovery Technologies Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Discovery Technologies Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical companies
12.4.2. Pharmaceutical companies
12.4.3. Research institutes
12.4.4. Biotech companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Discovery Technologies Market Size and Volume Forecast by Type
12.7.1. Biochips
12.7.2. High throughput screening
12.7.3. Pharmacogenomics
12.7.4. Genomics
12.7.5. Bioanalytical instruments
12.7.6. Bioinformatics
12.7.7. Nanotechnology
12.7.8. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Discovery Technologies Demand Share, 2019-2029
13. Middle East & Africa Drug Discovery Technologies Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Discovery Technologies Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Discovery Technologies Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical companies
13.4.2. Pharmaceutical companies
13.4.3. Research institutes
13.4.4. Biotech companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Discovery Technologies Market Size and Volume Forecast by Type
13.7.1. Biochips
13.7.2. High throughput screening
13.7.3. Pharmacogenomics
13.7.4. Genomics
13.7.5. Bioanalytical instruments
13.7.6. Bioinformatics
13.7.7. Nanotechnology
13.7.8. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Discovery Technologies Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Drug Discovery Technologies Market: Market Share Analysis
14.2. Drug Discovery Technologies Distributors and Customers
14.3. Drug Discovery Technologies Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies, Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott Laboratories, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GE Healthcare Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Albany Molecular Research Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Affymetrix Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Arqule Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Luminex Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bayer Healthcare AG
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novartis AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Astrazeneca plc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
&n
